Rapid Micro Biosystems, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Rapid Micro Biosystems, Inc. (RPID) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$60.81 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2023-03-10
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-12-31 was -$16.45M.
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-09-30 was -$16.34M.
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-06-30 was -$13.09M.
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-03-31 was -$14.93M.
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$60.81M.
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for fiscal 2021 was -$78.03M.
- Rapid Micro Biosystems, Inc. net income (loss) available to common stockholders, diluted for fiscal 2020 was -$45.22M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$32.79M derived: sum of 2 quarters · filed 2023-03-10 | -$45.88M derived: sum of 3 quarters · filed 2023-03-10 | -$60.81M 10-K · filed 2023-03-10 |
| 2022-09-30 | -$16.34M 10-Q · filed 2022-11-10 | -$29.43M derived: sum of 2 quarters · filed 2022-11-10 | -$44.36M 10-Q · filed 2022-11-10 | -$58.96M derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-06-30 | -$13.09M 10-Q · filed 2022-08-12 | -$28.02M 10-Q · filed 2022-08-12 | -$42.63M derived: sum of 3 quarters · filed 2023-03-10 | -$67.85M derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-03-31 | -$14.93M 10-Q · filed 2022-05-10 | -$29.54M derived: sum of 2 quarters · filed 2023-03-10 | -$54.76M derived: sum of 3 quarters · filed 2023-03-10 | -$68.66M derived: sum of 4 quarters · filed 2023-03-10 |
| 2021-12-31 | -$14.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | -$39.83M derived: sum of 2 quarters · filed 2023-03-10 | -$53.73M derived: sum of 3 quarters · filed 2023-03-10 | -$78.03M 10-K · filed 2023-03-10 |
| 2021-09-30 | -$25.23M 10-Q · filed 2022-11-10 | -$39.13M derived: sum of 2 quarters · filed 2022-11-10 | -$63.43M 10-Q · filed 2022-11-10 | -$77.04M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$13.90M 10-Q · filed 2022-08-12 | -$38.20M 10-Q · filed 2022-08-12 | -$51.81M derived: sum of 3 quarters · filed 2022-08-12 | -$62.52M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$24.30M 10-Q · filed 2022-05-10 | -$37.91M derived: sum of 2 quarters · filed 2022-05-10 | -$48.62M derived: sum of 3 quarters · filed 2022-05-10 | -$59.91M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$13.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$24.32M derived: sum of 2 quarters · filed 2022-03-24 | -$35.61M derived: sum of 3 quarters · filed 2022-03-24 | -$45.22M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$10.71M 10-Q · filed 2021-11-15 | -$22.00M derived: sum of 2 quarters · filed 2021-11-15 | -$31.61M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$11.29M 10-Q · filed 2021-08-27 | -$20.90M 10-Q · filed 2021-08-27 |